What does Lakewood-Amedex Biotherapeutics Inc. do?

Lakewood-Amedex Biotherapeutics Inc. is a public company in the Pharmaceutical Preparations industry, incorporated in NV. It is registered with the SEC under CIK 0002079272 and trades on under the ticker LABT.

How many SEC filings has Lakewood-Amedex Biotherapeutics Inc. made?

Lakewood-Amedex Biotherapeutics Inc. has filed 6 documents with the SEC since 2025. These include annual reports (10-K), quarterly reports (10-Q), current event notices (8-K), and insider transaction disclosures (Form 4).

Lakewood-Amedex Biotherapeutics Inc.

LABT CIK: 0002079272 Pharmaceutical Preparations Inc. in NV

View on SEC.gov →

Overview All Filings Annual Quarterly Insiders

Recent Filings

All 6 filings →

Form	Description	Date
S-1/A	REGISTRATION STATEMENT	Mar 11, 2026
S-1/A	REGISTRATION STATEMENT	Feb 13, 2026
S-1/A	REGISTRATION STATEMENT	Feb 5, 2026
S-1	REGISTRATION STATEMENT	Jan 9, 2026
DRS/A	—	Oct 17, 2025
DRS	—	Jul 31, 2025

Insider Transactions

View all →

No insider transactions loaded yet.

About This Profile

This page aggregates all publicly available SEC EDGAR data for Lakewood-Amedex Biotherapeutics Inc.. Financial figures are sourced from XBRL-tagged 10-K annual reports. Insider transactions are sourced from Form 4 filings required within two business days of a transaction.

Key Financials

Financial data not yet loaded.

Details

CIK: 0002079272
Ticker: LABT
Incorporated: NV
First Filing: 2025
Total Filings: 6

Pharmaceutical Preparations rankings →